The 10th Anniversary of Medicines: Future Directions

Dear Colleagues,

The inaugural Special Issue of Medicines (63 pages) was released in December 2014 by the founding Editor-in-Chief Prof. Dr. Gerhard Litscher from Medical University of Graz (Austria). With the rapid advancement of science and technology, the editorial board has grown, with a second Editor-in-Chief (Prof. Dr. Hiroshi Sakagami from Meikai Research Institute of Odontology, Japan) since March 2020.

Among the 677 articles published so far, 270 articles have been cited 10 times or more, giving it an H5-Index of 35. In order to improve the quality of papers, Medicines has invited highly competent young researchers to be section board members. Due to the rigorous revision processes, the quality of submitted papers has considerably improved. This led to a significant increase in the number of paper views over the past five years (2019~2023): 2.0-fold (40,7281 to 81,2340).

In 2024, Medicines will celebrate its 10th anniversary; thus, we are planning to publish the Special Issue "The 10th Anniversary of Medicines: Future Directions", with a change in scope to be more focused on drugs. We hope that the editorial board member of each of the sections of Medicines will consider submitting their systematic reviews and articles on current and future research, including the development of new products and services that ultimately improve quality of life. This invitation is extended to all active researchers, clinical doctors, and practitioners with research interest in the field of therapeutic agents and advanced drug studies.

Prof. Dr. Hiroshi Sakagami
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.